Found: 13
Select item for more details and to access through your institution.
Extensive genetic and phenotypic description of MAPT p.R406W in the Flanders‐Belgian population.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.053069
- By:
- Publication type:
- Article
In‐depth phenotypic description of pathogenic TBK1 mutations: A frequent cause of FTD and ALS in the Flanders‐Belgian population.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.052900
- By:
- Publication type:
- Article
ABCA7 PTC mutation carriers present with Alzheimer's disease pathology and cerebral amyloid angiopathy: Basic science and pathogenesis: Genetics and omics of AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041513
- By:
- Publication type:
- Article
P1‐237: IMPROVED DIAGNOSTIC ACCURACY USING THE CEREBROSPINAL FLUID AMYLOID BETA 1‐42/1‐40 RATIO.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P327, doi. 10.1016/j.jalz.2019.06.792
- By:
- Publication type:
- Article
P4‐270: NEUROGRANIN IN CEREBROSPINAL FLUID IS NOT SPECIFIC TO ALZHEIMER'S DISEASE DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1549, doi. 10.1016/j.jalz.2018.07.092
- By:
- Publication type:
- Article
P2‐228: PRE‐ANALYTICAL STABILITY OF NOVEL CEREBROSPINAL FLUID BIOMARKERS FOR DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P755, doi. 10.1016/j.jalz.2018.06.915
- By:
- Publication type:
- Article
SARS‐CoV‐2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.
- Published in:
- Transboundary & Emerging Diseases, 2022, v. 69, n. 5, p. 3016, doi. 10.1111/tbed.14219
- By:
- Publication type:
- Article
DIFFERENTIAL ROLE OF CSF FATTY ACID BINDING PROTEIN 3, α-SYNUCLEIN AND ALZHEIMER’S DISEASE CORE BIOMARKERS IN LEWY BODY DISORDERS AND ALZHEIMER’S DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P334, doi. 10.1016/j.jalz.2017.06.057
- By:
- Publication type:
- Article
PLASMA NEUROFILAMENT LIGHT CONCENTRATION PREDICTS LONG-TERM OUTCOME IN ACUTE STROKE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1158, doi. 10.1016/j.jalz.2016.07.068
- By:
- Publication type:
- Article
A DECADE OF CEREBROSPINAL FLUID BIOMARKERS FOR ALZHEIMER’S DISEASE IN BELGIUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P467, doi. 10.1016/j.jalz.2016.06.918
- By:
- Publication type:
- Article
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0276-4
- By:
- Publication type:
- Article
Optimization and Application of a Multiplex Digital PCR Assay for the Detection of SARS-CoV-2 Variants of Concern in Belgian Influent Wastewater.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 3, p. 610, doi. 10.3390/v14030610
- By:
- Publication type:
- Article